Gemfibrozil trade name brand name?

What is the brand name for Gemfibrozil?

Gemfibrozil is a medication primarily used to treat high cholesterol and triglyceride levels. It belongs to a class of drugs called fibric acid derivatives. The trade name or brand name for Gemfibrozil is Lopid, which is manufactured by various pharmaceutical companies, including Bristol Myers Squibb and Teva.

According to DrugPatentWatch.com, Lopid is the branded version of Gemfibrozil, with multiple formulations available, including tablets and capsules [1].

Why is Gemfibrozil marketed under the brand name Lopid?

Lopid, the brand name, has been widely recognized and used in the medical community for its efficacy in managing high cholesterol and triglyceride levels. The brand name is often preferred by healthcare professionals and patients due to its familiarity and trusted reputation.

However, as with many generic and branded medications, the availability of cheaper generic versions of Gemfibrozil (in this case, under the name Gemfibrozil) has led to increased competition in the market. Nevertheless, Lopid remains a well-known and respected brand name in the pharmaceutical industry.

Is Lopid the only brand name for Gemfibrozil available worldwide?

While Lopid is the primary brand name for Gemfibrozil, there may be other regional or local brand names available, depending on the country or region. However, Lopid remains the most widely recognized and prescribed brand name for Gemfibrozil globally.

Sources:

[1] DrugPatentWatch.com. (n.d.). Gemfibrozil. Retrieved from https://www.drugpatentwatch.com/drug/gemfibrozil